Couldn’t be more happier to reconnect with my forever mentor and big brother @md_SsAhmad, and the future super star fellow @MFerranteDO @UCincyIM @MCWcardiology
We’re incredibly proud of our outstanding PGY3, @D_E_McDuffie, for presenting his work on applying implementation science to enhance adherence to spontaneous breathing trials in our medical ICU! Way to go David! @CincyIM@accpchest#CHEST2024
The game just changed in cardiology! 🫀
Coronary CT #CCTA can now assess coronary microvascular dysfunction – a huge leap forward in diagnosing and treating microvascular disease. 🌟
This could reshape how we approach #CMD
🔥Just published @JACCJournals https://t.co/29oD74bmRD
Check out this excellent article by @CardioBusiness about our new #ASEGuideline, "Recommendations for Multimodality Imaging of Patients With Left Ventricular Assist Devices and Temporary Mechanical Support!"
Had an incredible time at my first American Society of Nuclear Cardiology conference presenting a case series highlighting the various arrhythmias that cardiac sarcoidosis can present with. Nuclear imaging has proven 🔑 to early identification of infiltrative CM. #ASNC24
Grateful for the opportunity to present a very interesting case on cardiac sarcoidosis at the American Society of Nuclear Cardiology conference!!
@MyASNC#ASNC2024
@UCincyIM @uccardiology
@PourriahiMD
Nothing to ‘SCOFF’ at! New research out of #ESCCongress suggests fasting prior to cath lab procedures requiring conscious sedation may not be needed. Read more: https://t.co/JKiz6lvan9
Female gender was removed from CHADS-VASc score in new ESC guidelines for management of AF.
Rationale : female gender is a risk modifier rather than risk factor for stroke.
Now we have a CHADS-VA score.
BREAKING 📰: The US FDA has approved a shift in #HeartFailure management after the ARIES-HM3 trial revealed aspirin avoidance had positive results for newly implanted adult #HeartMate3#LVAD patients.
Learn more: https://t.co/cGekuCcm5D
US Safety Info: https://t.co/gBlQdYVfVK
The ARTESIA trial showed that anticoagulation reduces adverse events compared with aspirin among patients with subclinical #AFib.
Read updates to the trial on treatment differences according to CHA2DS2-VASc: https://t.co/2tKL321etp #Stroke
Our new paper in @NEJM examines the widespread acquisitions of medical practices by UnitedHealth, Humana, Cigna, and other insurers—what’s driving this trend and what are its implications for patients and clinicians? 1/x
🚨Exciting News! #JSCAI is accepted for PubMed Central Indexing!🎉
Read @AlexandraLansky's editorial:
➡️https://t.co/eQVlmXEXYV
📢This significant milestone boosts our authors' visibility, citation rates, and recognition by making all articles more accessible to researchers and practitioners.
♥️Thank you to our Editors, Authors, Reviewers, and everyone for their unwavering support in making this possible. @SCAI